Daewoong Pharmaceutical Obtains Approval for SGLT2i + Metformin Combination Drug Envlomet

Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination drug in just one month after the release of Envlo Tab., the 1st SGLT-2 inhibitor by Korea, expanding its product...

Related Keywords

,Daewoong Pharmaceutical ,Envlo Tab ,Markets ,